Asia-Pacific CDMO Market Share Analysis, Industry Trends & Growth Forecasts 2024-2029: Demand For Injectable Dose Formulation is Rising in the Market
September 23, 2024 05:47 ET
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)" report has been added to ...
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
September 19, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
September 12, 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
September 12, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
September 12, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources
September 10, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024
September 09, 2024 16:05 ET
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 06, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
BioConnection appoints Richard Sewalt as New Chief Commercial Officer
September 06, 2024 03:43 ET
|
BioConnection
OSS, The Netherlands – 6 September 2024, BioConnection, a leading Dutch contract development and manufacturing organization (CDMO) in the pharmaceutical industry, today announced the appointment of...
Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
September 05, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...